Grove Bank & Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $178K | Sell |
1,720
-249
| -13% | -$22.2K | 0.02% | 280 |
|
|
2026
Q1 | $141K | Sell |
1,969
-91
| -4% | -$7.01K | 0.02% | 299 |
|
|
2025
Q4 | $163K | Sell |
2,060
-201
| -9% | -$15.8K | 0.02% | 276 |
|
|
2025
Q3 | $170K | Buy |
2,261
+99
| +5% | +$6.79K | 0.02% | 265 |
|
|
2025
Q2 | $149K | Buy |
2,162
+502
| +30% | +$32.9K | 0.02% | 281 |
|
|
2025
Q1 | $112K | Sell |
1,660
-75
| -4% | -$4.49K | 0.02% | 304 |
|
|
2024
Q4 | $77.9K | Buy |
1,735
+444
| +34% | +$24.9K | 0.01% | 317 |
|
|
2024
Q3 | $81.2K | Sell |
1,291
-1,977
| -60% | -$115K | 0.01% | 316 |
|
|
2024
Q2 | $193K | Sell |
3,268
-110
| -3% | -$6.88K | 0.03% | 223 |
|
|
2024
Q1 | $269K | Sell |
3,378
-250
| -7% | -$19.1K | 0.05% | 188 |
|
|
2023
Q4 | $286K | Sell |
3,628
-1,055
| -23% | -$75.1K | 0.05% | 187 |
|
|
2023
Q3 | $327K | Sell |
4,683
-46
| -1% | -$3.26K | 0.07% | 168 |
|
|
2023
Q2 | $327K | Sell |
4,729
-733
| -13% | -$52.2K | 0.07% | 177 |
|
|
2023
Q1 | $406K | Buy |
5,462
+503
| +10% | +$42.2K | 0.09% | 154 |
|
|
2022
Q4 | $462K | Buy |
4,959
+45
| +0.9% | +$4.34K | 0.1% | 151 |
|
|
2022
Q3 | $469K | Buy |
4,914
+30
| +0.6% | +$2.97K | 0.12% | 140 |
|
|
2022
Q2 | $453K | Hold |
4,884
| – | – | 0.11% | 143 |
|
|
2022
Q1 | $494K | Buy |
4,884
+540
| +12% | +$56.7K | 0.1% | 148 |
|
|
2021
Q4 | $448K | Buy |
4,344
+159
| +4% | +$14.7K | 0.09% | 158 |
|
|
2021
Q3 | $355K | Buy |
4,185
+135
| +3% | +$11.3K | 0.07% | 173 |
|
|
2021
Q2 | $338K | Sell |
4,050
-18
| -0.4% | -$1.47K | 0.07% | 173 |
|
|
2021
Q1 | $306K | Hold |
4,068
| – | – | 0.07% | 173 |
|
|
2020
Q4 | $278K | Buy |
4,068
+568
| +16% | +$36.9K | 0.07% | 168 |
|
|
2020
Q3 | $204K | Sell |
3,500
-69
| -2% | -$4.29K | 0.06% | 176 |
|
|
2020
Q2 | $232K | Buy |
+3,569
| New | +$225K | 0.08% | 161 |
|
|
2020
Q1 | – | Sell |
-3,479
| Closed | -$258K | – | 169 |
|
|
2019
Q4 | $258K | Sell |
3,479
-100
| -3% | -$7.02K | 0.08% | 166 |
|
|
2019
Q3 | $226K | Buy |
+3,579
| New | +$212K | 0.07% | 163 |
|
|
2018
Q1 | – | Sell |
-2,136
| Closed | -$155K | – | 233 |
|
|
2017
Q4 | $155K | Hold |
2,136
| – | – | 0.07% | 183 |
|
|
2017
Q3 | $174K | Buy |
2,136
+1,656
| +345% | +$131K | 0.08% | 171 |
|
|
2017
Q2 | $39K | Buy |
+480
| New | +$37.9K | 0.02% | 280 |
|
|
2016
Q4 | – | Sell |
-3,644
| Closed | -$324K | – | 582 |
|
|
2016
Q3 | $324K | Buy |
3,644
+980
| +37% | +$92.5K | 0.28% | 76 |
|
|
2016
Q2 | $255K | Sell |
2,664
-62
| -2% | -$6.18K | 0.23% | 81 |
|
|
2016
Q1 | $283K | Buy |
2,726
+175
| +7% | +$17K | 0.26% | 74 |
|
|
2015
Q4 | $250K | Buy |
+2,551
| New | +$250K | 0.22% | 81 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
CGH
Grove Bank & Trust's CVS Position: Q2 2026 in Review
Grove Bank & Trust reduced its CVS Health (CVS) stake by 13% in Q2 2026, selling an estimated $22.2K and leaving 1,720 shares worth $178K. The position accounts for 0.02% of the portfolio, ranked #280.
Grove Bank & Trust first reported a position in CVS in Q4 2015 and has held it in 34 quarters since. The position peaked at $494K in Q1 2022. 505 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Grove Bank & Trust held 1,720 shares of CVS Health worth $178K as of Q2 2026.
- Grove Bank & Trust sold 249 CVS Health shares in Q2 2026, an estimated $22.2K.
- CVS Health made up 0.02% of Grove Bank & Trust's portfolio in Q2 2026, its #280 holding.
- Grove Bank & Trust first reported a position in CVS Health in Q4 2015 and has held it in 34 quarters since.
- Grove Bank & Trust's CVS Health position peaked at $494K in Q1 2022.
- 505 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.